Jacqueline D. Shields

5.9k total citations · 1 hit paper
38 papers, 4.3k citations indexed

About

Jacqueline D. Shields is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jacqueline D. Shields has authored 38 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 18 papers in Immunology and 16 papers in Molecular Biology. Recurrent topics in Jacqueline D. Shields's work include Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (7 papers) and CAR-T cell therapy research (6 papers). Jacqueline D. Shields is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (7 papers) and CAR-T cell therapy research (6 papers). Jacqueline D. Shields collaborates with scholars based in United Kingdom, United States and Switzerland. Jacqueline D. Shields's co-authors include Melody A. Swartz, Alice A. Tomei, Hafsa Munir, Carla P. Martins, Matthew A. Lakins, Ehsan Ghorani, Angela Riedel, Joanna Roberts, Iraklis C. Kourtis and Gwendalyn J. Randolph and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Jacqueline D. Shields

37 papers receiving 4.3k citations

Hit Papers

Cancer-associated fibroblasts induce antigen-specific del... 2018 2026 2020 2023 2018 100 200 300 400

Peers

Jacqueline D. Shields
Laura M. Calvi United States
Paola Divieti Pajevic United States
Charles K. F. Chan United States
Tero Kivelä Finland
Shelly Heimfeld United States
Francesca Ferraro United States
Arun D. Singh United States
Laura M. Calvi United States
Jacqueline D. Shields
Citations per year, relative to Jacqueline D. Shields Jacqueline D. Shields (= 1×) peers Laura M. Calvi

Countries citing papers authored by Jacqueline D. Shields

Since Specialization
Citations

This map shows the geographic impact of Jacqueline D. Shields's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacqueline D. Shields with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacqueline D. Shields more than expected).

Fields of papers citing papers by Jacqueline D. Shields

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacqueline D. Shields. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacqueline D. Shields. The network helps show where Jacqueline D. Shields may publish in the future.

Co-authorship network of co-authors of Jacqueline D. Shields

This figure shows the co-authorship network connecting the top 25 collaborators of Jacqueline D. Shields. A scholar is included among the top collaborators of Jacqueline D. Shields based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacqueline D. Shields. Jacqueline D. Shields is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wray, Richard, Ferdia A. Gallagher, Iosif Mendichovszky, et al.. (2025). Angiogenic and immune predictors of neoadjuvant axitinib response in renal cell carcinoma with venous tumour thrombus. Nature Communications. 16(1). 3870–3870. 1 indexed citations
2.
Munir, Hafsa, et al.. (2024). Modeling Structural Elements and Functional Responses to Lymphatic‐Delivered Cues in a Murine Lymph Node on a Chip. Advanced Healthcare Materials. 13(18). e2303720–e2303720. 8 indexed citations
3.
Huang, Yan Yan Shery, et al.. (2024). Advancing tumor microenvironment and lymphoid tissue research through 3D bioprinting and biofabrication. Advanced Drug Delivery Reviews. 217. 115485–115485. 2 indexed citations
4.
Clark, Paula A., Noé Rodríguez‐Rodríguez, Ana C. F. Ferreira, et al.. (2024). Recipient tissue microenvironment determines developmental path of intestinal innate lymphoid progenitors. Nature Communications. 15(1). 7809–7809. 5 indexed citations
5.
Lei, Iek Man, et al.. (2023). Deployable extrusion bioprinting of compartmental tumoroids with cancer associated fibroblasts for immune cell interactions. Biofabrication. 15(2). 25005–25005. 30 indexed citations
6.
Nowicki-Osuch, Karol, Lizhe Zhuang, Tik Shing Cheung, et al.. (2023). Single-Cell RNA Sequencing Unifies Developmental Programs of Esophageal and Gastric Intestinal Metaplasia. Cancer Discovery. 13(6). 1346–1363. 32 indexed citations
7.
Munir, Hafsa, James O. Jones, Tobias Janowitz, et al.. (2021). Stromal-driven and Amyloid β-dependent induction of neutrophil extracellular traps modulates tumor growth. Nature Communications. 12(1). 683–683. 129 indexed citations
8.
Mahata, Bidesh, Jhuma Pramanik, Louise van der Weyden, et al.. (2020). Tumors induce de novo steroid biosynthesis in T cells to evade immunity. Nature Communications. 11(1). 3588–3588. 265 indexed citations
9.
Mayes, Eric, et al.. (2019). Impact of Locally Administered Carboxydextran‐Coated Super‐Paramagnetic Iron Nanoparticles on Cellular Immune Function. Small. 15(20). e1900224–e1900224. 12 indexed citations
10.
Muliaditan, Tamara, Jonathan Caron, James W. Opzoomer, et al.. (2018). Macrophages are exploited from an innate wound healing response to facilitate cancer metastasis. Nature Communications. 9(1). 2951–2951. 90 indexed citations
11.
Lakins, Matthew A., Ehsan Ghorani, Hafsa Munir, Carla P. Martins, & Jacqueline D. Shields. (2018). Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells. Nature Communications. 9(1). 948–948. 437 indexed citations breakdown →
12.
Riedel, Angela, David Shorthouse, Lisa Haas, Benjamin A. Hall, & Jacqueline D. Shields. (2016). Tumor-induced stromal reprogramming drives lymph node transformation. Nature Immunology. 17(9). 1118–1127. 134 indexed citations
13.
Hu, Yanping, Jacqueline D. Shields, Tri‐Hung Nguyen, et al.. (2011). Enhancement of the anti-tumor activity of therapeutic monoclonal antibodies by CXCR4 antagonists. Leukemia & lymphoma. 53(1). 130–138. 24 indexed citations
14.
Shields, Jacqueline D.. (2011). Lymphatics: At the Interface of Immunity, Tolerance, and Tumor Metastasis. Microcirculation. 18(7). 517–531. 15 indexed citations
15.
Shields, Jacqueline D., Iraklis C. Kourtis, Alice A. Tomei, Joanna Roberts, & Melody A. Swartz. (2010). Induction of Lymphoidlike Stroma and Immune Escape by Tumors That Express the Chemokine CCL21. Science. 328(5979). 749–752. 394 indexed citations
16.
Siders, William, Jacqueline D. Shields, Yanping Hu, et al.. (2010). Involvement of neutrophils and natural killer cells in the anti-tumor activity of alemtuzumab in xenograft tumor models. Leukemia & lymphoma. 51(7). 1293–1304. 61 indexed citations
17.
Issa, Amine, Thomas X. Le, Alexander N. Shoushtari, Jacqueline D. Shields, & Melody A. Swartz. (2008). Vascular Endothelial Growth Factor-C and C-C Chemokine Receptor 7 in Tumor Cell–Lymphatic Cross-talk Promote Invasive Phenotype. Cancer Research. 69(1). 349–357. 160 indexed citations
18.
Hu, Yanping, Jacqueline D. Shields, Lisa Woodworth, et al.. (2007). Alemtuzumab activity and CD52 expression in human CD52 transgenic mice. Cancer Research. 67. 4133–4133.
19.
Siders, William, et al.. (2003). Induction of specific antitumor immunity in the mouse with the electrofusion product of tumor cells and dendritic cells. Molecular Therapy. 7(4). 498–505. 62 indexed citations
20.
Robinson, Max, et al.. (2003). Functional significance of MMP-2 and MMP-9 expression by human malignant oral keratinocyte cell lines. Archives of Oral Biology. 48(11). 779–786. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026